PPA
VBIV

Parametric Portfolio Associates’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Parametric Portfolio Associates’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$102K Sell
2,045
-1,253
-38% -$61.9K ﹤0.01% 3559
2021
Q4 		$232K Sell
3,298
-1,133
-26% -$95.5K ﹤0.01% 3368
2021
Q3 		$413K Sell
4,431
-30
-0.7% -$2.85K ﹤0.01% 3181
2021
Q2 		$448K Sell
4,461
-138
-3% -$13.5K ﹤0.01% 3132
2021
Q1 		$429K Buy
4,599
+2,238
+95% +$227K ﹤0.01% 3568
2020
Q4 		$195K Buy
2,361
+874
+59% +$74.5K ﹤0.01% 3784
2020
Q3 		$128K Buy
1,487
+1,013
+214% +$118K ﹤0.01% 3748
2020
Q2 		$44K Buy
+474
New +$26.1K ﹤0.01% 3873

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return